Vitrolife AB (publ) (VTRLY)
USD 19.8
(0.0%)
USD 19.8
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -3.19 Billion SEK | 16.38% |
| 2022 | 977 Million SEK | 72.43% |
| 2021 | 579 Million SEK | 30.01% |
| 2020 | 452.34 Million SEK | -25.4% |
| 2019 | 594.38 Million SEK | 23.29% |
| 2018 | 483.75 Million SEK | 18.4% |
| 2017 | 408.31 Million SEK | 33.99% |
| 2016 | 304.04 Million SEK | 15.71% |
| 2015 | 281.09 Million SEK | 56.1% |
| 2014 | 171.13 Million SEK | 36.08% |
| 2013 | 116.52 Million SEK | 59.9% |
| 2012 | 71.64 Million SEK | 86.91% |
| 2011 | 49.34 Million SEK | -18.54% |
| 2010 | 50.83 Million SEK | 67.17% |
| 2009 | 30.4 Million SEK | 12.1% |
| 2008 | 27.12 Million SEK | 31.18% |
| 2007 | 20.67 Million SEK | 24.61% |
| 2006 | 16.59 Million SEK | -25.13% |
| 2005 | 22.16 Million SEK | 69.95% |
| 2004 | 13.04 Million SEK | -70.54% |
| 2003 | 41.87 Million SEK | -64.5% |
| 2002 | 124.69 Million SEK | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 347 Million SEK | -20.22% |
| 2024 Q1 | 265 Million SEK | 106.57% |
| 2024 Q3 | 173 Million SEK | -20.28% |
| 2023 Q2 | 187 Million SEK | 17.61% |
| 2023 Q4 | 304 Million SEK | 68.89% |
| 2023 FY | - SEK | 16.38% |
| 2023 Q1 | 159 Million SEK | 67.37% |
| 2023 Q3 | 180 Million SEK | -3.74% |
| 2022 Q2 | 174 Million SEK | 29.85% |
| 2022 Q1 | 134 Million SEK | 79.8% |
| 2022 Q4 | 95 Million SEK | -46.63% |
| 2022 Q3 | 178 Million SEK | 2.3% |
| 2022 FY | - SEK | 72.43% |
| 2021 Q3 | 142.18 Million SEK | 27.93% |
| 2021 Q4 | 74.52 Million SEK | -47.58% |
| 2021 Q1 | 142.47 Million SEK | -2.14% |
| 2021 Q2 | 111.14 Million SEK | -21.99% |
| 2021 FY | - SEK | 30.01% |
| 2020 FY | - SEK | -25.4% |
| 2020 Q1 | 93.8 Million SEK | -32.05% |
| 2020 Q2 | 16.41 Million SEK | -82.51% |
| 2020 Q4 | 145.59 Million SEK | 29.45% |
| 2020 Q3 | 112.47 Million SEK | 585.38% |
| 2019 Q2 | 122.93 Million SEK | 18.74% |
| 2019 Q4 | 138.05 Million SEK | 5.8% |
| 2019 Q1 | 103.53 Million SEK | -3.13% |
| 2019 FY | - SEK | 23.29% |
| 2019 Q3 | 130.47 Million SEK | 6.13% |
| 2018 Q3 | 104.03 Million SEK | 5.64% |
| 2018 Q4 | 106.87 Million SEK | 2.73% |
| 2018 Q1 | 89.66 Million SEK | 2.66% |
| 2018 FY | - SEK | 18.4% |
| 2018 Q2 | 98.48 Million SEK | 9.83% |
| 2017 Q3 | 81.1 Million SEK | -14.27% |
| 2017 FY | - SEK | 33.99% |
| 2017 Q4 | 87.34 Million SEK | 7.69% |
| 2017 Q2 | 94.6 Million SEK | 20.81% |
| 2017 Q1 | 78.31 Million SEK | -1.15% |
| 2016 Q2 | 61.78 Million SEK | 18.76% |
| 2016 Q4 | 79.22 Million SEK | 39.74% |
| 2016 FY | - SEK | 15.71% |
| 2016 Q1 | 52.01 Million SEK | -27.63% |
| 2016 Q3 | 56.69 Million SEK | -8.23% |
| 2015 Q1 | 39.45 Million SEK | -2.93% |
| 2015 Q3 | 66.19 Million SEK | 31.06% |
| 2015 Q2 | 50.5 Million SEK | 28.01% |
| 2015 Q4 | 71.87 Million SEK | 8.59% |
| 2015 FY | - SEK | 56.1% |
| 2014 Q3 | 43.71 Million SEK | 30.1% |
| 2014 Q2 | 33.6 Million SEK | 12.31% |
| 2014 Q4 | 40.64 Million SEK | -7.03% |
| 2014 Q1 | 29.92 Million SEK | 30.42% |
| 2014 FY | - SEK | 36.08% |
| 2013 Q4 | 22.94 Million SEK | -0.62% |
| 2013 FY | - SEK | 59.9% |
| 2013 Q1 | 16.95 Million SEK | -23.99% |
| 2013 Q2 | 18.63 Million SEK | 9.91% |
| 2013 Q3 | 23.08 Million SEK | 23.88% |
| 2012 Q1 | 15.1 Million SEK | 271.05% |
| 2012 Q3 | 14.64 Million SEK | 8.12% |
| 2012 Q2 | 13.54 Million SEK | -10.37% |
| 2012 Q4 | 22.3 Million SEK | 52.36% |
| 2012 FY | - SEK | 86.91% |
| 2011 FY | - SEK | -18.54% |
| 2011 Q1 | 10.13 Million SEK | -61.44% |
| 2011 Q4 | 4.07 Million SEK | -71.65% |
| 2011 Q3 | 14.36 Million SEK | 14.06% |
| 2011 Q2 | 12.59 Million SEK | 24.25% |
| 2010 FY | - SEK | 67.17% |
| 2010 Q4 | 26.28 Million SEK | 347.66% |
| 2010 Q3 | 5.87 Million SEK | -32.35% |
| 2010 Q2 | 8.67 Million SEK | -13.25% |
| 2010 Q1 | 10 Million SEK | 50.94% |
| 2009 Q4 | 6.62 Million SEK | -7.89% |
| 2009 Q2 | 7.79 Million SEK | 0.0% |
| 2009 FY | - SEK | 12.1% |
| 2009 Q3 | 7.19 Million SEK | -7.67% |
| 2008 FY | - SEK | 31.18% |
| 2007 FY | - SEK | 24.61% |
| 2006 FY | - SEK | -25.13% |
| 2005 FY | - SEK | 69.95% |
| 2004 FY | - SEK | -70.54% |
| 2003 FY | - SEK | -64.5% |
| 2002 FY | - SEK | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Heart Tronics, Inc. | -14.85 Million USD | -21391.731% |
| Lombard Medical, Inc. | -28.06 Million USD | -11275.944% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 57927.179% |
| Wellstar International, Inc. | -1.35 Million USD | -235282.059% |
| Össur hf. | 137.38 Million USD | 2424.193% |
| QHSLab, Inc. | -91.29 Thousand USD | -3497429.931% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| REMSleep Holdings, Inc. | -1.66 Million USD | -191263.3% |
| BrainsWay Ltd. | -2.31 Million USD | -138065.296% |
| Electromedical Technologies, Inc. | -1.72 Million USD | -185336.31% |
| Bionovate Technologies Corp | - USD | Infinity% |
| Theraclion SA | -2.05 Million USD | -155596.401% |
| Avitar, Inc. | -1.66 Million USD | -191349.47% |
| AVITA Medical, Inc. | -39.56 Million USD | -7969.701% |
| Aurora Spine Corporation | -454.37 Thousand USD | -702618.882% |
| SS Innovations International, Inc. | -20.37 Million USD | -15570.404% |
| Nanomix Corporation | -8.13 Million USD | -39127.167% |
| CVR Medical Corp. | - USD | Infinity% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Össur hf. | 137.38 Million USD | 2424.193% |
| BioElectronics Corporation | -274.29 Thousand USD | -1163996.394% |
| ECGI Holdings, Inc. | -2.99 Million USD | -106673.871% |
| Zecotek Photonics Inc. | -3.44 Million USD | -92659.932% |
| Stratec SE | 39.91 Million USD | 8099.699% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 32767.993% |
| Escalon Medical Corp. | -58.46 Thousand USD | -5461660.832% |
| Ingen Technologies, Inc. | -8639.00 USD | -36960196.331% |
| Odyssey Group International, Inc. | -2.13 Million USD | -149240.013% |
| Guided Therapeutics, Inc. | -3.12 Million USD | -102043.314% |
| Polarean Imaging plc | -11.19 Million USD | -28421.684% |
| NewCardio, Inc. | -9.37 Million USD | -33942.954% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | -621076.013% |
| Vivos Inc. | -2.79 Million USD | -114215.542% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | -1615046.871% |
| MicroPort Scientific Corporation | -347.57 Million USD | -818.642% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -842589.216% |
| VMS Rehab Systems, Inc. | -68.55 USD | -4657913831.437% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 700227.176% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | -451507.428% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | -274212.715% |
| Positron Corporation | -1.45 Million USD | -219780.715% |
| Rafina Innovations Inc. | - USD | Infinity% |
| ALR Technologies Inc. | -6.4 Million USD | -49788.17% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 3163271.295% |
| SANUWAVE Health, Inc. | -9.15 Million USD | -34788.553% |
| IR-Med Inc. | -4.89 Million USD | -65169.828% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | -23949.385% |
| United American Healthcare Corporation | -59 Thousand USD | -5411764.407% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | -507383.514% |
| Urologix, Inc. | -6.34 Million USD | -50231.021% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | -257532.764% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | -2699905.919% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | -416758.69% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | -1432908.105% |
| Smith & Nephew plc | 1 Billion USD | 418.476% |
| NIOX Group Plc | 11.07 Million USD | 28930.439% |
| Fuse Medical, Inc. | 1.83 Million USD | 174075.49% |
| Broncus Holding Corporation | -25.19 Million USD | -12571.231% |
| Brain Scientific Inc. | -7.93 Million USD | -40145.907% |
| Pressure BioSciences, Inc. | -9.39 Million USD | -33900.986% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | -17353160.87% |